Key Events This Week
2025-12-31: Death Cross formation signalling bearish trend
2026-01-01: Bearish momentum intensifies despite intraday gains
2026-01-02: Week closes at Rs.300.55 (+1.55% weekly)
Jan 29
BSE+NSE Vol: 6.3 lacs

Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 21 Nov 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 28 January 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Advanced Enzyme Technologies Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s Mojo Grade was downgraded from Hold to Sell on 21 Nov 2025, reflecting deteriorating technical conditions and a weakening price trajectory amid broader market pressures.
Read full news article
Advanced Enzyme Technologies Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from bearish to mildly bearish territory. Despite a modest day gain of 1.37%, the stock’s broader technical landscape reveals a complex interplay of bearish and bullish signals, prompting a reassessment of its near-term outlook within the Pharmaceuticals & Biotechnology sector.
Read full news article
Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 21 Nov 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 06 January 2026, providing investors with the latest comprehensive view of the company’s position.
Read full news article
2025-12-31: Death Cross formation signalling bearish trend
2026-01-01: Bearish momentum intensifies despite intraday gains
2026-01-02: Week closes at Rs.300.55 (+1.55% weekly)

Advanced Enzyme Technologies Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend across multiple timeframes. Despite a modest day gain of 1.25%, the stock’s broader technical outlook has deteriorated, prompting a downgrade in its Mojo Grade from Hold to Sell as of 21 Nov 2025. This article analyses the recent price momentum, technical indicator signals, and the implications for investors in the Pharmaceuticals & Biotechnology sector.
Read full news article
Advanced Enzyme Technologies Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a prolonged bearish trend, reflecting deteriorating momentum and long-term weakness in the stock’s price action.
Read full news article
Recent Price Movement and Market Performance
The stock’s fall on 26-Dec was marked by an intraday low of ₹295.20, representing a 3.95% dip from previous levels. Trading volumes skewed towards the lower price range, indicating selling pressure. Advanced Enzyme Technologies is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a bearish technical outlook. Additionally, investor participation has waned, with delivery volumes on 24 Dec falling by 16.33% compared to the five-day average, suggesting reduced conviction among shareholders.
Over the short term, the stock has underperformed the Sensex and its sector. In the past week, it declined by 3.90%, while the Sensex gained 0.13%. The one-month pe...
Read full news article
Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and outlook.
Read full news articleAdvanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2026 inter alia to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31 2025.
Intimation regarding conversion of Statutory Audit Firm from M S K A & Associates to M S K A & Associates LLP Chartered Accountants effectived from January 13 2026
Please find enclosed herewith compliance certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended December 31 2025.
31 Jan 2026
Advanced Enzyme Technologies Ltd has declared 60% dividend, ex-date: 23 Jul 25
Advanced Enzyme Technologies Ltd has announced 2:10 stock split, ex-date: 25 May 17
No Bonus history available
No Rights history available